DIA415.36+6.58 1.61%
SPX5,638.94+117.42 2.13%
IXIC17,754.09+451.07 2.61%

What's Going On With Palantir Technologies Stock Today?

Benzinga·03/14/2025 12:46:49
Listen to the news

Palantir Technologies Inc (NASDAQ:PLTR) shares are trading higher in premarket on Friday.

Revenue cycle management (RCM) company, R1 has joined forces with Palantir Technologies Inc (NASDAQ:PLTR), known for its expertise in artificial intelligence (AI), to create an innovative AI lab named R37.

The partnership seeks to transform healthcare financial outcomes by creating advanced automation solutions.

By combining R1’s deep understanding of payer-provider relationships with Palantir’s AI technology, the lab aims to streamline healthcare reimbursement processes more efficiently.

R1 works with 94 of the top 100 U.S. health systems, giving it a strong position to drive changes in the RCM industry.

Also Read: What’s Going On With EV Charging Provider ChargePoint’s Stock Today?

By integrating Palantir's advanced AI technology with R1's vast data, R37 is set to deliver faster, more accurate and scalable reimbursement results for healthcare organizations.

The partnership comes at a time when administrative costs in U.S. hospitals now exceed 40% of their total expenses, amounting to over $160 billion annually.

With increasing economic pressures and complex payer relationships, the need for AI-driven solutions in healthcare reimbursement has never been greater.

R37 will focus on automating labor-intensive tasks such as coding, billing and denials management to improve efficiency, accuracy and cash flow.

In the initial phase, R37 has developed AI-powered solutions that are already yielding positive results in early-stage testing. R1 plans to roll out comprehensive ‘agentic RCM worker' solutions to enterprise customers in the second half of 2025, aiming to further optimize the revenue cycle process.

Price Action: PLTR shares traded higher by 3.08% at $82.07 in premarket at last check.

Read Next: Meta’s Community Notes To Replace Third-Party Fact Checkers

Photo: Shutterstock

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.